Floatz logo

Cyclophosphamide

Fallopian Tube Serous Adenocarcinoma

Roswell Park Cancer InstituteSmall moleculePhase 2Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

28 Active assets in the Fallopian Tube Serous Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
National Cancer Institute (NCI)
Phase 3BBB
Olaparib
NRG Oncology
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
Ohio State University Comprehensive Cancer Center
Phase 3BB
Inno-206
National Cancer Institute (NCI)
Phase 2/3BB
Cediranib
National Cancer Institute (NCI)
Phase 2/3BB

View all 39 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →